The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed Placing and Subscription

25 Apr 2014 07:00

RNS Number : 4934F
Imaginatik PLC
25 April 2014
 



 

Imaginatik Plc

("Imaginatik" or the "Company")

 

Proposed Issue of Equity and Notice of General Meeting

 

Imaginatik plc (AIM: IMTK.L), the world's first full service innovation provider offering a range of technology products and consultancy, is pleased to announce that, following a strong show of support from existing and new investors, it has conditionally raised £1.338m (before expenses) to provide additional working capital to fund the development of the Group's business.

The Fundraising will be effected through the issue of 1,911,428,572 new Ordinary Shares with new and existing investors, including certain of the Directors, in each case at the Issue Price, being 0.07 pence per new Ordinary Share. The Issue Price represents a premium of 12.0 per cent to the issue price per Ordinary Share the last time the Company raised capital, a year ago. The Board believes that, whilst small, this nevertheless represents a significant indication of the increased confidence which investors have in our Company, confidence which the Board very much shares. This is borne out by the fact that each member of the Board is participating in the Fundraising.

 

The Issue Price is equal to the closing mid-market price of 0.07 pence per Ordinary Share on 24 April 2014, the latest practicable dealing day prior to the publication of this document. The New Ordinary Shares will represent in aggregate 36.75 per cent. of the Enlarged Share Capital.

 

Matt Cooper, Executive Chairman of Imaginatik, commented:

"In any business breaking new ground with relatively new offerings, it takes time to gain real and sustainable traction and the Board feels Imaginatik is making good progress. We have seen growth in new customer wins, strong customer retention and a solid increase in the sales pipeline over the past year. This confidence means that each of the Board members has participated in the fundraising and we are delighted that several of our largest shareholders have similarly shown their support and belief in the Company through investing. The funds raised last year have enabled us to recruit high calibre individuals into the sales team and we expect to see the benefits of this in the year ahead. These new funds will enable us to recruit a new CEO to lead the Company through this next phase of growth. We are confident we have a sensible strategy to succeed in the emerging innovation market."

 

Background to and reasons for the Fundraising

 

The market for the provision of innovation technology and consulting services continues to develop well, with industry analysts Forrester and Gartner now following and writing about the sector. The Directors believe that the Company's repositioning within the space over the last couple of years as a provider of a range of innovation solutions combining both technology and consulting rather than pure technology is a sensible strategy that will benefit the Company in the long run. This repositioning has removed the reliance on a single offering and has allowed the Company to move away from selling to technologists with a limited budget, to selling into more senior executives with a longer term vision for how a sustained innovation competence can help benefit their businesses.

 

In the last year the Company has increased both the size and capability of the sales team in the US. The impact on the Company's business of this new team is yet to be felt, but the sales pipeline has grown substantially in the last year, from approximately $6m in April 2013 to $10.8m in April 2014.

 

As the Company stated in its trading statement released on 14 April 2014, it continues to add new clients and its roster of blue chip clients grows, adding 15 in the year to March 2014 in a mixture of annual license contracts as well as consulting engagements. The Company is witnessing its consulting revenues becoming a more important part of the Company's overall revenue mix, and the Company has added a series of additional consulting offerings in the last 12 months, which are being well received by its client base.

 

Client retention has been very good; 14 clients out of 16 whose contracts were up for renewal in the year to 31 March 2014 chose to re-contract with the Company, four of which entered into multi-year contracts.

 

In any business breaking new ground with relatively new offerings, it takes time to gain real and sustainable traction, but the Board feels the Company has made good progress since the beginning of the Company's last financial year in further establishing and restructuring the sales team and adding further service offerings. However, the business is still in need of cash in order to continue its development and make progress towards reaching that break-even point and becoming a self sustaining business. The Company proposes to invest some of the proceeds of the Fundraising in hiring a new CEO as referred to in the paragraph below and on increasing the Company's marketing activities by hiring additional personnel as and when the Board considers it is prudent to do so.

 

It is the Board's intention to hire a full time CEO for the business. With the assistance of a US based search firm which the Company has engaged, that process is now underway, and the Board expects to be in a position to advise shareholders on progress later in the year. At the point that the Company secures the services of a suitable candidate, Matt Cooper will become the Non-Executive Chairman of the Company. Furthermore, David Gammon has indicated that he intends stepping down as a non-executive director of the Company upon completion of the Placing as he feels that he has overseen and contributed to a key stage of the Company's development. The Board thanks him hugely for his strategic and wise counsel since the time of his appointment and wishes him well for the future. At that point, Mr Charles will assume the chairmanship of the audit committee in addition to that of the remuneration committee.

 

The Directors have concluded that effecting the Company's recapitalisation by way of the Fundraising is the most efficient way to source the funds required. As has previously been the case, the Directors did consider the possibility of effecting the recapitalisation by way of an open offer to all existing Shareholders, but considered that given (i) the considerably greater expense to the Company involved in effecting an open offer, (ii) the greater length of time it would take to effect an open offer in contrast to the relatively swift timetable of the Fundraising, and (iii) the Company had previously undertaken the expense and time of seeking a recapitalisation by way of an open offer in the past which did not generate a material uptake, it was considered the Fundraising to be the preferable and most efficient way to source the present funds required.

 

The Placing and Subscription

 

The Company has conditionally raised approximately £1.263m in aggregate (before expenses) pursuant to the Placing and the Subscription. The net proceeds of the Placing and the Subscription receivable by the Company are estimated to be approximately £1.19m.

 

Pursuant to the terms of the Placing Agreement, finnCap has conditionally agreed, as agent for the Company, to use its reasonable endeavours to procure subscribers for 861,428,572 Placing Shares with institutional and other investors at the Issue Price. The Issue Price is equal to the closing mid-market price of an Ordinary Share on 24 April 2014, being the last dealing day prior to the announcement of the Placing. In addition, the Company has procured subscribers for 942,857,143 Subscription Shares at the Issue Price pursuant to the Subscription Agreements. The Placing Shares and the Subscription Shares will represent in aggregate 36.75 per cent. of the Enlarged Share Capital. This is the first time in the Company's history of issuing equity that it has agreed to issue Ordinary Shares at a higher price per Ordinary Share than the previous fundraise. The Directors believe this shows that the Company is now in a much more confident and stable place than it has been for some time.

 

The Placing has not been underwritten. The Placing Agreement and Subscription Agreements are conditional, inter alia, upon:

 

1. the Resolution being duly passed at the General Meeting;

 

2. Admission becoming effective on or before 8.00 a.m. on 13 May 2014 or such later time and/or date as finnCap may agree in its absolute discretion, but in any event by no later than 8.00 a.m. on 30 May 2014.

 

The Placing Shares will upon their issue rank pari passu in all respects with the Existing Ordinary Shares including the right to receive all dividends or other distributions declared, made or paid by the Company following Admission.

Director's Future Subscription

 

In addition to the £1.263m conditionally raised with new and existing investors pursuant to the Placing and Subscription, Simon Charles, a non-executive director of the Company, has irrevocably agreed to subscribe for 107,142,857 new Ordinary Shares at the Issue Price on or before 31 October 2014. Accordingly, together with the proceeds raised from the Placing and Subscription, the Company has conditionally raised, in aggregate, £1.338m gross and £1.265m net of estimated expenses. This subscription (and share issue) is deferred due to Mr Charles having to implement appropriate financial arrangements to enable full settlement of his subscription obligations to occur and accordingly he will not be issued any new Ordinary Shares until the Company is fully in funds in respect of his subscription commitments. The Director's Future Subscription is conditional upon, inter alia, the Resolution being duly passed at the General Meeting.

 

Working Capital

The Directors believe that the net proceeds of the Fundraising will be sufficient for the Company's present and anticipated requirements for a period of not less than twelve months following Admission.

 

Expected Admission Dates

Application will be made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM. It is expected that Admission will occur at 8.00 a.m. on 13 May 2014. Following Admission, the total number of shares in issue will be 4,908,980,456.

 

Application will be made to the London Stock Exchange for the Director's Future Subscription Shares to be admitted to trading on AIM before 31 October 2014.

 

Directors' participations in the Fundraising

 

David Gammon, Shawn Taylor and Matt Cooper have in aggregate given commitments to subscribe in person or by a nominee, for Subscription Shares as follows:

 

 

Director

Number of Existing Ordinary Shares (excluding interests in options)

Percentage of Existing Ordinary Shares

Number of Subscription Shares to be acquired

Number of Ordinary Shares after Completion

 

Percentage of Enlarged Share Capital

Matt Cooper

311,821,407

10.0%

714,285,715

1,026,107,122

20.9%

David Gammon

140,442,564

4.5%

85,714,286

226,156,850

4.6%

Shawn Taylor

17,903,558

0.6%

7,142,857

25,046,415

0.5%

 

As announced by the Company on 14 April 2014, Mr Cooper has provided loans to the Company of an aggregate value of £96,666 and as part of the Subscription, it is agreed that he pay the Company a net balance of £403,334 and capitalise the loan amount currently outstanding so his aggregate participation under the Subscription is an amount of £500,000, equating to 714,285,715 Subscription Shares at the Issue Price.

 

In addition, Simon Charles has committed to subscribe for the Director's Future Subscription Shares. His interest in the Ordinary Shares now and following the Director's Future Subscription is as follows:

 

 

Director

Number of Existing Ordinary Shares (excluding interests in options)

Percentage of Existing Ordinary Shares

Number of Director's Future Subscription Shares

Number of Ordinary Shares following issue of Director's Future Subscription Shares

 

Percentage of enlarged share capital following issue of Placing Shares and Director's Future Subscription Shares

Simon

Charles

59,511,771

1.9%

107,142,857

166,654,628

3.4%

 

Note: The above tables exclude the Directors' interests to subscribe for new Ordinary Shares under options granted to them by the Company.

 

Directors' Authority to issue and allot further Ordinary Shares

 

In the light of the encouraging response to the Fundraising, the Board considers that it would also be beneficial to both the Company and Shareholders if the Company were authorised to retain an element of flexibility to allot and issue (out with the Fundraising), as a whole or in tranches, Ordinary Shares (and/or rights to subscribe to them) up to the aggregate nominal value of £613,623 (representing 20 per cent. of the Enlarged Share Capital) to meet any unforeseen future working capital requirements or opportunities which the Board believes would be earnings enhancing for the Company.

 

Related Party Transactions

 

The participation of the Directors and the participation by Hargreave Hale Limited, as a substantial shareholder in the Company, in the Fundraising constitute related party transactions for the purposes of Rule 13 of the AIM Rules (the "Related Party Transactions"). There are no independent directors for the purposes of providing the fair and reasonable statement required under Rule 13 of the AIM Rules. finnCap, the Company's nominated adviser, considers that the terms of the Related Party Transactions are fair and reasonable insofar as Shareholders are concerned. 

 

Circular and Notice of General Meeting

 

A circular setting out the background to and further details of the Fundraising will today be sent to Shareholders along with a notice convening the General Meeting to be held at 10.30 a.m. on 12 May 2014 at the offices of Marriott Harrison LLP, 11 Staple Inn, London WC1V 7QH, at which the Resolution will be proposed for the purposes of implementing the Fundraising.

 

The Resolution is required to grant the Directors sufficient authority under the Act to allot and issue the New Ordinary Shares and the Director's Future Subscription Shares and additional new Ordinary Shares (and rights to subscribe therefor) for a par value of £613,623 representing 20 per cent. of the Enlarged Share Capital.

Capitalised terms used in this announcement and not otherwise defined shall have the same meaning given to them in the circular dated 25 April 2014 ("Circular"). The Circular is available on the Company's website: www.imaginatik.com.

For further information please contact:

 

Imaginatik plc

Tel: 01329 243243

Matt Cooper, Executive Chairman / Shawn Taylor, CFO

 

finnCap

Tel: 0207 220 0500

Charlotte Stranner/ Victoria Bates

 

Newgate Threadneedle

Tel: 020 7653 9850

Caroline Forde / Hilary Millar

 

About Imaginatik

 

Imaginatik® is the world's first full-service innovation provider. We have 16 years of experience building innovation into a sustainable competence at some of the world's largest and most respected companies. Through a mix of consulting and advisory, hands-on innovation projects and program management, and our award-winning enterprise software platform, we help clients develop innovation capability into a permanent competitive advantage. Imaginatik is the trusted partner of leading organisations including Blue Cross Blue Shield, CSC, Cargill, The World Bank, Mayo Clinic, The Chubb Group of Insurance Companies, HCA, Dow Chemical and Goodyear.

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and is a World Economic Forum Technology Pioneer with offices in Boston, MA, and Fareham, UK. For more information visit www.imaginatik.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEZMGZDFDFGDZZ
Date   Source Headline
30th Dec 20193:10 pmRNSHalf-year Report
2nd Dec 20197:00 amRNSFinal Results
13th Nov 20197:00 amRNSAppointment of Joint Broker
28th Oct 20193:03 pmRNSDirector Declaration
27th Sep 201911:30 amRNSUpdate, Proposed Transaction and RPT
5th Sep 20194:18 pmRNSDirectorate Change
6th Aug 20197:31 amRNSRe Suspension and Update
6th Aug 20197:30 amRNSSuspension - Abal Group Plc
2nd Aug 20199:49 amRNSUpdate on suspension date
24th Jun 20199:11 amRNSUpdate on Board Changes
3rd May 20192:01 pmRNSHolding(s) in Company
3rd May 20199:00 amRNSPrice Monitoring Extension
2nd May 201911:55 amRNSHolding(s) in Company
1st May 201911:01 amRNSHolding(s) in Company
1st May 201910:58 amRNSHolding(s) in Company
29th Apr 201910:28 amRNSHolding(s) in Company
26th Apr 201911:52 amRNSHolding(s) in Company
5th Apr 20192:22 pmRNSHolding(s) in Company
1st Apr 20198:10 amRNSUpdate on Board changes
1st Mar 20197:00 amRNSUpdate and Directorate Change
5th Feb 201911:48 amRNSHolding(s) in Company
5th Feb 201910:08 amRNSCompletion of disposal
5th Feb 20198:23 amRNSHolding(s) in Company
31st Jan 20195:30 pmRNSImaginatik
31st Jan 201910:09 amRNSHolding(s) in Company
30th Jan 20199:38 amRNSHolding(s) in Company
28th Jan 201910:27 amRNSResult of GM
14th Jan 20197:00 amRNSIssue of Equity
10th Jan 20197:00 amRNSProposed sale of business and assets
13th Dec 20183:42 pmRNSHolding(s) in Company
12th Dec 201812:37 pmRNSResult of AGM
10th Dec 20183:47 pmRNSHolding(s) in Company
4th Dec 20182:10 pmRNSHolding(s) in Company
4th Dec 20189:23 amRNSHolding(s) in Company
3rd Dec 20183:01 pmRNSIssue of Equity
3rd Dec 20187:00 amRNSContract Award
28th Nov 20183:33 pmRNSHolding(s) in Company
28th Nov 20187:00 amRNSHolding(s) in Company
27th Nov 20187:00 amRNSResult of Open Offer
19th Nov 20187:00 amRNSHalf-year Report
16th Nov 20187:00 amRNSNotice of AGM
8th Nov 201812:52 pmRNSDirectorate Change
2nd Nov 20185:29 pmRNSHolding(s) in Company
2nd Nov 20187:00 amRNSOpen Offer
31st Oct 201812:37 pmRNSAdmission of new shares
26th Oct 20187:30 amRNSRestoration - Imaginatik plc
26th Oct 20187:00 amRNSAppointment of NOMAD and Completion of Placing
18th Oct 20187:00 amRNSCompany Update
1st Oct 20187:00 amRNSCompany Update
28th Sep 201811:01 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.